Stay updated on Phase 1/2 Pacritinib & Sirolimus for GVHD Prevention Clinical Trial

Sign up to get notified when there's something new on the Phase 1/2 Pacritinib & Sirolimus for GVHD Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 1/2 Pacritinib & Sirolimus for GVHD Prevention Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page history now lists Revision: v3.3.2, replacing v3.2.0. This appears to be a routine system release update rather than a change to study content or user-facing functionality.
    Difference
    0.1%
    Check dated 2025-11-25T11:49:06.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The notice about government funding and potential delays was removed from the page. This banner previously informed users about data reliability and operating status.
    Difference
    0.4%
    Check dated 2025-11-18T07:18:53.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The Record History page now shows additional recent versions with updated submission dates and status notes. The version history appears longer, reflecting ongoing updates to the study record.
    Difference
    0.1%
    Check dated 2025-11-03T21:22:59.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Adds current date (2025-10-10) and a new study status entry (2025-09-30), while removing an older date (2025-06-13. Overall, updates to time-sensitive content and status tracking.
    Difference
    0.8%
    Check dated 2025-10-13T11:54:47.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Summary: The page now displays a government-operating-status notice and announces a software version upgrade to v3.2.0, replacing the old v3.1.0.
    Difference
    9%
    Check dated 2025-10-06T07:53:39.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other substantive content changes detected.
    Difference
    0.2%
    Check dated 2025-09-29T04:15:39.000Z thumbnail image

Stay in the know with updates to Phase 1/2 Pacritinib & Sirolimus for GVHD Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 1/2 Pacritinib & Sirolimus for GVHD Prevention Clinical Trial page.